Summarized by Masters of Longevity from PR Newswire.
Announcement of a collaboration to apply AI-driven digital pathology for preclinical evaluation and characterization of therapies targeting fibrotic diseases.
Key Takeaways
- HistoIndex and A*STAR signed a Memorandum of Understanding to collaborate on preclinical evaluation of antifibrotic candidates.
- HistoIndex will supply its stain-free imaging and AI quantitative tissue analysis to measure fibrosis and treatment response.
